Phase I study of fotemustine in pediatric patients with refractory brain tumors.
about
Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposiumA comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.
P2860
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
@ast
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
@en
type
label
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
@ast
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
@en
prefLabel
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
@ast
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
@en
P2093
P2860
P356
P1433
P1476
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
@en
P2093
Janet Gammon
Nauman Tariq
Ron M Grant
Sylvain Baruchel
P2860
P304
P356
10.1002/CNCR.10814
P407
P577
2002-09-01T00:00:00Z